AKT1 and metabolic dysfunction-associated steatotic liver disease: Furthermore, our recent study has illustrated that puerarin is an effective and practical regimen for NAFLD by regulating PARP-1/PI3K/AKT signaling pathway, further promoting mitochondrial function (17).